ClinicalTrials.Veeva

Menu

Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography

Hologic logo

Hologic

Status

Completed

Conditions

Breast Cancer

Treatments

Device: Tomosynthesis digital mammography imaging system

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

This was a multi-center, prospective clinical trial in which the subject was her own control. Approximately 950-1400 female subjects were enrolled at five (5) sites in the United States. Subjects were from either a Screening population or a biopsy population and were imaged first on a conventional 2D full filed digital mammography system then on a 3D tomosynthesis system.

The resulting images from the this portion of the study were then randomized into a reader study.

The purpose of this clinical study was to compare the 3-D tomosynthesis system used in conjunction with a conventional 2-D digital imaging system (2-D plus 3-D images) to the conventional 2-D digital imaging system (2-D images), and to determine whether the 2-D plus 3-D images compared to the 2-D images alone would:

  1. Reduce the recall rate And/or
  2. Improve ROC area due to improved breast cancer detection and/or improved lesion classification.

Enrollment

1,183 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • Any ethnic origin
  • No contraindication for screening mammography

Exclusion criteria

  • Significant breast trauma
  • Pregnancy
  • Lactating
  • Breast implants
  • Previous breast cancer
  • Previous surgical biopsy
  • Placement of an internal breast marker
  • Unable to understand and or execute written informed consent

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems